Genomics in Scotland strategy: Fairer Scotland Duty summary
Fairer Scotland Duty impact assessment (FSD) summary for the Genomics in Scotland: Building our Future - a five-year national strategy (2024-2029).
Footnotes
1. Sequeira AR Mentzakis E, Archangelidi O, Paolucci F. The economic and health impact of rare diseases: A meta-analysis. Health Policy and Technology. 10:1. 2021.32-44.
2. Abbott M, McKenzie L, Moran BVG, Heidenreich S, Hernández R, Hocking-Mennie L, Clark C, Gomes J, Lampe A, Baty D, McGowan R, Miedzybrodzka Z, Ryan M. (2022). Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland. J Community Genet. Oct;13(5):487-501. doi: 10.1007/s12687-021-00541-4. Epub 2021 Aug 20. PMID: 34415556; PMCID: PMC9530076.
3. Public Health Scotland, Cancer Incidence in Scotland. A National Statistics release for Scotland. 2022.
4. Public Health Scotland, Cancer Mortality. Annual update to 2021. A National Statistics release for Scotland. 2022.
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback